Showing 4 posts of 4 posts found.


MHRA to extend EpiPen expiry dates to tackle shortages

October 18, 2018
Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen

The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …


Roche’s Alecensa receives second FDA Breakthrough Therapy Designation

October 4, 2016
Manufacturing and Production ALK+, Alecensa, FDA, Roche, alk, crizotinib

Alecensa has been designated as a breakthrough therapy, which will speed up the process towards FDA approval, should clinical trials …

Roche image

Roche lung cancer drug sees first approval

July 4, 2014
Sales and Marketing ALK+, Cancer, NSCLC, Pfizer, Roche, Xalkori, alectinib, alk, zykadia

Roche has seen the first approval for its new lung cancer drug alectinib in Japan as it looks to compete …

Promising signs for Novartis’ lung cancer drug

June 4, 2013
Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis

Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …

Latest content